Actor or casting combination that consistently underperforms theatrically — regardless of material or budget. Insurance nightmare for financiers.
The phenomenon occurs when an established actor or a specific cast combination consistently leads to box office results that do not recoup the budget across multiple productions — regardless of script quality, direction, or marketing volume. This becomes a serious problem for line producers and financiers: insurance companies will insure expensive films at a higher rate if such names are involved, or refuse coverage altogether. Studios quickly learn to avoid certain constellations.
The causes are rarely monocausal. Sometimes it was a resounding flop — not because of the actor, but due to a disastrous script or a director in freefall. However, the industry tends to simplify: the name becomes a brand for failure, and every subsequent project carries this stigma. A good practical example: a well-known character actor who had sunk two consecutive large budgets was suddenly only offered roles in low-budget projects or niche segments — even though his acting performance was never in question. The problem was not the performer, but the perceived market dynamics.
Important: This is fundamentally different from simply "not being bankable." Box office poison implies active destruction — a track record of flops, not just a lack of star power. Some actors have never had A-list status and are nevertheless successful in their segment. Box office poison is the inverse problem: you have visibility, but it acts like a bug in the marketing code.
Casting directors and producers now understand the phenomenon better. They distinguish between a flop that was systemic (editing, budget misplanning, release timing) and a flop that was truly due to the constellation. Nevertheless: insurance companies work with rigid data. Anyone who has grossed below expectations three times in a row will pay the premium for it next time — no matter how solid the new project is.